about
CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosisNeuroinflammation in motor neuron diseaseTargeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issueMicroglia centered pathogenesis in ALS: insights in cell interconnectivityGap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseasesTherapeutic neuroprotective agents for amyotrophic lateral sclerosisEarly functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosisThe omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosisStem cells in human neurodegenerative disorders--time for clinical translation?Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during agingProtective Microglia and Their Regulation in Parkinson's DiseaseG-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trialExendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosisAblation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutaseMultiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALSMicroglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis.Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology.Ablation of keratan sulfate accelerates early phase pathogenesis of ALS.Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?Human glial progenitor engraftment and gene expression is independent of the ALS environmentControl of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disordersPathology of callosal damage in ALS: An ex-vivo, 7 T diffusion tensor MRI studyContributions of microglia to structural synaptic plasticityNP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker studyMicroglia in central nervous system diseasesTransformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosisRac1 at the crossroad of actin dynamics and neuroinflammation in Amyotrophic Lateral Sclerosis.Reimagining Alzheimer's disease--an age-based hypothesis.Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.Role of microglia in ethanol's apoptotic action on hypothalamic neuronal cells in primary cultures.Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cellsMicroglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosisMolecular imaging of microglial activation in amyotrophic lateral sclerosis.Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis.Progress in therapy development for amyotrophic lateral sclerosisMelatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model
P2860
Q21132045-15D72DD4-9D80-4C14-9006-80C408B771C9Q26776339-38C5B687-E672-4DF6-96D2-8A822425E5E6Q26852041-24770F3C-0F91-4D2C-8150-B44B6CF60079Q27009559-A3FA188D-641C-46AE-A5DB-31A89B1685A8Q27012316-EFAFF125-F1CF-42CE-AA25-01EDCFF7B824Q27015029-99A64226-E6CF-4469-A16F-FD10DC0CCC3BQ27303916-4365936D-70FD-41A9-9A1C-BD5897CA7920Q27324363-3A26BD9D-5353-413B-BA22-3CB1598BC70EQ27687068-7B98780A-39F0-4D3D-A7E5-2B8B5A51D8ACQ28077869-6554F4BE-9672-4A84-96A0-2ED22D9281D1Q28079731-D2485D8E-CFAD-4E59-877A-D070708DF6CDQ28477416-2BBCBCE3-E0D2-4E36-91C8-5D9DA72EDF6DQ28481242-7A39E2AD-062D-44B3-BA4E-EB00F370627AQ28482371-4843B04A-1B02-4ECF-ACF6-3F6CBAE8DC3BQ28732245-D447EC5B-AA6D-4F88-8CE8-D71CDD21069EQ30575638-6B3ADDBA-5D9F-437A-B867-A4EA5FC36DB4Q31058247-6280FA5E-72FE-4880-8B4A-B825546F8CFAQ31122599-BD9A454C-ADEF-486A-B1FF-1FD661605819Q33361835-2954F56C-FB7C-4CC3-B77B-486848404B0CQ33361902-27863CED-F14F-447D-91E4-432EB211504CQ33620690-D33E9038-A924-4EA1-BDCD-6B7CA7FA5EB8Q33670805-73A5F96C-5A4F-4CC3-97C1-5B03559A25F6Q33676258-8BB44E4A-DF63-4CC9-84D5-7B58C3E2F08AQ33873289-F8E27355-FD0F-45C5-8CC7-1BFE03F4ADE7Q33924917-19C9A0C9-A559-4A9B-B234-216B160390D8Q34014927-28F0D83D-19C6-4076-94BD-CA02A0686B58Q34019767-805F0ACC-239E-4C1F-8728-A6A7274890FFQ34081777-BD54ADB5-59F9-49FB-BEEC-E33293E967C5Q34148669-33790E6A-6300-4AD1-87AB-3B9F45064565Q34155080-68C88B65-EBAD-493F-9958-0043D6260C79Q34168523-E9EAE7FB-B1BF-4651-BD4B-FC9CC7ACCEFEQ34246911-838BC8F9-6698-4781-A89D-E6C60FC6815FQ34292392-80EBD008-96F3-44C6-AAE2-6C5487C6F023Q34312322-EF6D5462-07DA-4D6E-96C7-AF7CD488302AQ34541448-DBE0BAAE-78AF-4EC2-A5C6-48375DEDA4DBQ34623581-4B41CF05-9AD1-474C-9E0A-B5C1650F207FQ34640800-DDE13F56-83C0-48A8-8E57-65232A417BF2Q34640994-174AC491-0C77-4F37-AFF6-4B98B9369F37Q34669342-C04E0A18-30C3-4B59-8142-524CB0F1E007Q34746889-EE433C0A-C945-41DD-AC51-4DCD9E824C4C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Microglia in ALS: the good, the bad, and the resting.
@en
Microglia in ALS: the good, the bad, and the resting.
@nl
type
label
Microglia in ALS: the good, the bad, and the resting.
@en
Microglia in ALS: the good, the bad, and the resting.
@nl
prefLabel
Microglia in ALS: the good, the bad, and the resting.
@en
Microglia in ALS: the good, the bad, and the resting.
@nl
P2093
P2860
P1476
Microglia in ALS: the good, the bad, and the resting.
@en
P2093
David R Beers
Jenny S Henkel
Weihua Zhao
P2860
P2888
P304
P356
10.1007/S11481-009-9171-5
P577
2009-12-01T00:00:00Z